Venous thromboembolism in multiple sclerosis: a report of two cases with pulmonary embolism on dimethyl fumarate and available data from adverse event reporting systems. Time to include disease modifying drugs in the equation?

Athanasios Papathanasiou,Rasha Abdel-Fahim,Christopher Gilmore,Nikos Evangelou

Clinical Neurology and Neurosurgery（2020）

引用 4|浏览3

暂无评分

摘要

•MS has been associated with an increased risk for VTE.•In our cases, DMF was a possible triggering factor for PE.•High number of VTE cases was found on adverse event reporting systems.•Further work is needed to establish DMTs role in VTE.

查看译文

关键词

Dimethyl fumarate,Pulmonary embolism,Venous thromboembolism,Multiple sclerosis,Disease modifying treatment

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要